F10 and acute kidney injury: However, during the observation period, the incidence of AKI was significantly higher in the warfarin group compared with dabigatran and anti-factor Xa inhibitor groups (10.2% vs. 4.3% vs. 5.4%; p <  0.001) (Table 3).